VanEck Video Gaming and eSports ETF vs Hinge Health Inc. Class A Common Stock — how do they compare? VanEck Video Gaming and eSports ETF trades at $99.09 (market cap $256.17M), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 33.1× VanEck Video Gaming and eSports ETF's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, VanEck Video Gaming and eSports ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold VanEck Video Gaming and eSports ETF for 68 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| ESPO | HNGE | |
|---|---|---|
Market Cap | $256.17M | $8.48B |
Volume | 17,642 | 879,799 |
Sector | Sector/Thematic | Health |
52-Week High | $116.66 | $105.14 |
52-Week Low | $85.25 | $31.17 |
Typical Hold Time | 68 Days | 0 Days |
Enterprise Value | — | $8.10B |
Signals from Pluang's Aura AI — not financial advice
ESPO trades at $100.43, up 0.08% today, with a bullish technical signal driven by strong moving average alignment. Key support lies at $97 and resistance at $98–$99. Financial ratios like P/E and P/S are unavailable in current data, limiting fundamental clarity. Recent news coverage is sparse, leaving sentiment largely neutral.
The stock's near-term outlook hinges on upcoming earnings to validate its technical strength. Risks include limited fundamental visibility and market volatility. Institutional positioning data is needed to gauge Wall Street confidence. Upside potential exists if resistance breaks, but caution is warranted without fresh catalysts.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.
Read more on ESPO →Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →